美國醫療保健 3PL（第三方物流）市場規模、份額和趨勢分析報告：2023-2030 年按行業、供應鏈、服務類型、地區、細分市場劃分的趨勢

美國醫療保健 3PL（第三方物流）市場增長和趨勢

GrandView Research, Inc. 的最新報告顯示，到 2030 年，美國醫療保健 3PL（第三方物流）市場預計將達到 1,608 億美元。

由於美國在藥品和生物製品市場的主導地位、大量參與者的存在以及生物製藥進出口的增加，預計該市場在預測期內的複合年增長率為 9.04%。

COVID-19 大流行期間，該國對 COVID-19 疫苗的高需求促使醫院、公共機構和其他機構與第三方物流服務提供商合作。 例如，2020 年，俄亥俄州衛生部與 Cardinal Health 合作分發了 COVID-19 疫苗。 預計這將改善疫情期間該國對第三方物流服務的需求。

在日本，用於治療癌症、自身免疫性疾病、神經系統疾病等的生物製藥的需求正在增加。 此外，日本正在進行大量的藥物研究。 所有這些因素預計將在預測期內增加對第三方物流服務的需求。

過去五年，大量藥品、生物製藥和醫療器械在該國獲得批准和上市。 例如，2023年1月，Amgen Pipeline推出了Amgevita生物仿製藥，用於治療活動性多關節型幼年特發性關節炎。 同樣，2022 年 12 月，美國 FDA 批准 Briambi 的 ublituximab-xiiy 用於治療多發性硬化症。 預測期內類似藥物在美國的批准和上市預計將為美國的第三方物流服務創造機會。

此外，市場主要參與者的戰略舉措預計將為未來幾年的區域市場提供增長機會。 例如，2023 年 1 月，Censinet 獲得 900 萬美元資金，用於加速醫療保健領域的第三方風險管理。 本輪融資由 MemorialCare Innovation Fund 領投，其中包括 Ballad Ventures 和 Rex Health Ventures，使該公司的融資總額超過 2200 萬美元。

美國醫療保健 3PL（第三方物流）市場亮點

• 按行業劃分，生物製藥領域佔據市場主導地位，2022 年份額超過 61.00%。 該領域的增長是由技術進步和推出的生物仿製藥數量增加推動的。
• 另一方面，冷鏈物流行業預計將在未來幾年佔據較大的市場份額。 這是由於美國對溫度敏感的藥品、生物製品、疫苗和其他醫療保健產品的需求增加。
• 按服務類型劃分，倉儲領域到 2022 年將佔 43.29% 的份額，能夠提供溫控存儲、符合監管標準並提供庫存管理解決方案。因為
• 由於醫療保健基礎設施健全、藥品製造商集中以及交通基礎設施健全等因素，2022 年中西部地區在美國醫療保健 3PL（第三方物流）行業中佔據主導地位。

內容

第一章調查方法及範圍

• 信息獲取
• 信息或數據分析
• 市場範圍和細分定義
• 市場模式

第 2 章執行摘要

• 市場概況
• 片段快照
• 競爭格局快照

第三章市場變量、趨勢和範圍

• 市場細分和範圍
• 市場體系展望
  • 母公司市場前景
  • 相關/補充市場前景
• 市場趨勢和展望
• 市場驅動因素分析
• 市場製約因素分析
• 商業環境分析
  • SWOT 分析；按因素（政治/法律、經濟/技術）
  • 波特五力分析
• COVID-19 感染的影響分析

第四章行業分析

• 美國醫療保健3PL（第三方物流）市場：行業波動分析
• 生物製藥
• 藥品
• 醫療設備

第五章供應鏈業務分析

• 美國醫療保健 3PL（第三方物流）市場：供應鏈波動分析
• 冷鏈
• 非冷鏈

第六章服務類型業務分析

• 美國醫療保健 3PL（第三方物流）市場：服務類型變化分析
• 交通
• 倉庫儲存
• 其他

第七章區域分析

• 美國醫療保健 3PL（第三方物流）市場：區域變化分析
• 東北
• 西南航空
• 西方
• 東南
• 中西部

第 8 章競爭格局

• 公司分類
• 2022 年公司市場分析
• 戰略規劃
• 參與公司概覽
  • ShipMonk
  • DHL International
  • Cardinal Health
  • MCKESSON CORPORATION
  • Kuehne+Nagel
  • AmerisourceBergen Corporation
  • CH Robinson
  • CEVA Logistics
  • Promptus, LLC
  • FedEx

U.S. Healthcare Third-party Logistics Market Growth & Trends

The U.S. healthcare third-party logistics market size is expected to reach USD 160.80 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to register a CAGR of 9.04% over the forecast period owing to the dominance of the U.S. in the pharmaceutical and biologics drugs market, the presence of a large number of players, and the rise in imports and exports of biopharmaceuticals.

High demand for COVID-19 vaccines in the country during the COVID-19 pandemic contributed to the hospitals, public organizations, and other institutions entering into partnerships with third-party logistics service providers. For instance, in 2020, the Ohio Department of Health partnered with Cardinal Health for the distribution of the COVID-19 vaccine. This is expected to have improved the demand for third-party logistics services in the country during the pandemic period.

There is a growing demand for biopharmaceuticals in the country for treating diseases such as cancer, autoimmune diseases, neurological diseases, and others. Furthermore, a significant number of researches are conducted in the country on drugs. All these factors are expected to boost the demand for third-party logistics services over the forecast period.

During the last five years, a significant number of pharmaceutical, biopharmaceutical, and medical devices were approved and launched in the country. For instance, in January 2023, Amgen launched Amjevita biosimilar for treating active polyarticular juvenile idiopathic arthritis. Similarly, in December 2022, the USFDA approved a drug named ublituximab-xiiy from Briumvi for treating multiple sclerosis. Similar drug approvals and drug launches in the country in the forecast period are expected to create opportunities for third-party logistics services in the U.S.

Furthermore, strategic initiatives undertaken by key entities in the market is expected to create growth opportunity for the regional market in the coming years. For instance, in January 2023, Censinet received funding of USD 9 million to accelerate third-party risk management in healthcare. This funding was led by the MemorialCare Innovation Fund including Ballad Ventures and Rex Health Ventures, bringing the Company's total funding to over USD 22 million.

U.S. Healthcare Third-party Logistics Market Highlights

• Based on industry, the biopharmaceutical segment dominated the market with a share of over 61.00% in 2022. The growth of the segment is attributed owing to technological advancements, and an increase in the number of biosimilar launches
• On the other hand, the cold chain logistics segment is expected to occupy a significant market share in the coming years. This is attributed due to the increasing demand for temperature-sensitive pharmaceuticals, biologics, vaccines, and other healthcare products in the U.S.
• Based on service type, the warehousing and storage segment captured the major share of 43.29% in 2022 owing to its capacity to offer temperature-controlled storage, adhere to regulatory standards, and provide inventory management solutions
• Midwest region dominated the U.S. healthcare third-party logistics industry in 2022 due to factors such as robust healthcare infrastructure, the concentration of pharmaceutical manufacturers, and robust transportation infrastructure

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Information Procurement
• 1.2. Information or Data Analysis
• 1.3. Market Scope & Segment Definition
• 1.4. Market Model

Chapter 2. Executive Summary

• 2.1. Market Snapshot
• 2.2. Segment Snapshot
• 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

• 3.1. Market Segmentation and Scope
• 3.2. Market Lineage Outlook
  • 3.2.1. Parent Market Outlook
  • 3.2.2. Related/Ancillary Market Outlook
• 3.3. Market Trends and Outlook
• 3.4. Market Driver Analysis
• 3.5. Market Restraint Analysis
• 3.6. Business Environment Analysis
  • 3.6.1. SWOT Analysis; By Factor (Political & Legal, Economic and Technological)
  • 3.6.2. Porter's Five Forces Analysis
• 3.7. COVID-19 Impact Analysis

Chapter 4. Industry Analysis

• 4.1. U.S. Healthcare Third-Party Logistics Market: Industry Movement Analysis
• 4.2. Biopharmaceutical
  • 4.2.1. Biopharmaceutical Market, 2018 - 2030 (USD Billion)
• 4.3. Pharmaceutical
  • 4.3.1. Pharmaceutical Market, 2018 - 2030 (USD Billion)
• 4.4. Medical Device
  • 4.4.1. Medical Device Market, 2018 - 2030 (USD Billion)

Chapter 5. Supply Chain Business Analysis

• 5.1. U.S. Healthcare Third-Party Logistics Market: Supply Chain Movement Analysis
• 5.2. Cold chain
  • 5.2.1. Cold chain Market, 2018 - 2030 (USD Billion)
• 5.3. Non-Cold chain
  • 5.3.1. Non-Cold Chain Market, 2018 - 2030 (USD Billion)

Chapter 6. Service Type Business Analysis

• 6.1. U.S. Healthcare Third-Party Logistics Market: Service Type Movement Analysis
• 6.2. Transportation
  • 6.2.1. Transportation Market, 2018 - 2030 (USD Billion)
    • 6.2.1.1. Air Freight
    • 6.2.1.1.1. Air freight Market, 2018 - 2030 (USD Billion)
    • 6.2.1.2. Sea freight
    • 6.2.1.2.1. Sea freight Market, 2018 - 2030 (USD Billion)
    • 6.2.1.3. Overland transportation
    • 6.2.1.3.1. Overland transportation Market, 2018 - 2030 (USD Billion)
• 6.3. Warehousing and storage
  • 6.3.1. Warehousing and storage Market, 2018 - 2030 (USD Billion)
• 6.4. Others
  • 6.4.1. Others Logistic Market, 2018 - 2030 (USD Billion)

Chapter 7. Region Analysis

• 7.1. U.S. Healthcare Third-Party Logistics Market: Region Movement Analysis
• 7.2. Northeast
  • 7.2.1. Northeast Healthcare Logistic Market, 2018 - 2030 (USD Billion)
• 7.3. Southwest
  • 7.3.1. Southwest Healthcare Logistic Market, 2018 - 2030 (USD Billion)
• 7.4. West
  • 7.4.1. West Healthcare Logistic Market, 2018 - 2030 (USD Billion)
• 7.5. Southeast
  • 7.5.1. Southeast Healthcare Logistic Market, 2018 - 2030 (USD Billion)
• 7.6. Midwest
  • 7.6.1. Midwest Healthcare Logistic Market, 2018 - 2030 (USD Billion)

Chapter 8. Competitive Landscape

• 8.1. Company Categorization
• 8.2. Company Market Position Analysis, 2022
• 8.3. Strategy Mapping
  • 8.3.1. Expansion
  • 8.3.2. Acquisition
  • 8.3.3. Collaborations
  • 8.3.4. New Product Launches
  • 8.3.5. Partnerships
  • 8.3.6. Others
• 8.4. Participant's overview
  • 8.4.1. ShipMonk
    • 8.4.1.1. Overview
    • 8.4.1.2. Financial Performance
    • 8.4.1.3. Product Benchmarking
    • 8.4.1.4. Strategic Initiatives
  • 8.4.2. DHL International
    • 8.4.2.1. Overview
    • 8.4.2.2. Financial Performance
    • 8.4.2.3. Product Benchmarking
    • 8.4.2.4. Strategic Initiatives
  • 8.4.3. Cardinal Health
    • 8.4.3.1. Overview
    • 8.4.3.2. Financial Performance
    • 8.4.3.3. Product Benchmarking
    • 8.4.3.4. Strategic Initiatives
  • 8.4.4. MCKESSON CORPORATION
    • 8.4.4.1. Overview
    • 8.4.4.2. Financial Performance
    • 8.4.4.3. Product Benchmarking
    • 8.4.4.4. Strategic Initiatives
  • 8.4.5. Kuehne+Nagel
    • 8.4.5.1. Overview
    • 8.4.5.2. Financial Performance
    • 8.4.5.3. Product Benchmarking
    • 8.4.5.4. Strategic Initiatives
  • 8.4.6. AmerisourceBergen Corporation
    • 8.4.6.1. Overview
    • 8.4.6.2. Financial Performance
    • 8.4.6.3. Product Benchmarking
    • 8.4.6.4. Strategic Initiatives
  • 8.4.7. C.H. Robinson
    • 8.4.7.1. Overview
    • 8.4.7.2. Financial Performance
    • 8.4.7.3. Product Benchmarking
    • 8.4.7.4. Strategic Initiatives
  • 8.4.8. CEVA Logistics
    • 8.4.8.1. Overview
    • 8.4.8.2. Financial Performance
    • 8.4.8.3. Product Benchmarking
    • 8.4.8.4. Strategic Initiatives
  • 8.4.9. Promptus, LLC
    • 8.4.9.1. Overview
    • 8.4.9.2. Financial Performance
    • 8.4.9.3. Product Benchmarking
    • 8.4.9.4. Strategic Initiatives
  • 8.4.10. FedEx
    • 8.4.10.1. Overview
    • 8.4.10.2. Financial Performance
    • 8.4.10.3. Product Benchmarking
    • 8.4.10.4. Strategic Initiatives

List of Tables

• Table 1. List of Secondary Sources
• Table 2. List of Abbreviations
• Table 3. Global U.S Healthcare Third-party Logistics Market by Industry, 2018 - 2030 (USD Billion)
• Table 4. U.S Healthcare Third-party Logistics Market by Supply Chain, 2018 - 2030 (USD Billion)
• Table 5. U.S Healthcare Third-party Logistics Market by Service Type, 2018 - 2030 (USD Billion)
• Table 6. U.S Healthcare Third-party Logistics Market by Region, 2018 - 2030 (USD Billion)
• Table 7. U.S Healthcare Third-party Logistics Market by End Use, 2018 - 2030 (USD Billion)
• Table 8. U.S Healthcare Third-party Logistics Market by Region, 2018 - 2030 (USD Billion)

List of Figures

• Fig. 1 Information Procurement
• Fig. 2 Primary Research Pattern
• Fig. 3 Market Research Approaches
• Fig. 4 Value Chain-Based Sizing & Forecasting
• Fig. 5 Market Formulation & Validation
• Fig. 6 U.S. Healthcare Third-party Logistics Market, Market Segmentation
• Fig. 7 Market Driver Relevance Analysis (Current & Future Impact)
• Fig. 8 Market Restraint Relevance Analysis (Current & Future Impact)
• Fig. 9 Market Challenge Relevance Analysis (Current & Future Impact)
• Fig. 10 Penetration & Growth Prospect Mapping
• Fig. 11 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
• Fig. 12 Porter's Five Forces Analysis
• Fig. 13 Market Penetration Vs Growth Prospect Mapping, 2021
• Fig. 14 Regional Marketplace: Key Takeaways
• Fig. 15 U.S. Healthcare Third-party Logistics Market for Biopharmaceutical, 2018 - 2030 (USD Billion)
• Fig. 16 U.S. Healthcare Third-party Logistics Market for Pharmaceutical, 2018 - 2030 (USD Billion)
• Fig. 17 U.S. Healthcare Third-party Logistics Market for Medical Device, 2018 - 2030 (USD Billion)
• Fig. 18 U.S. Healthcare Third-party Logistics Market for Cold Chain, 2018 - 2030 (USD Billion)
• Fig. 19 U.S. Healthcare Third-party Logistics Market for Non-cold Chain, 2018 - 2030 (USD Billion)
• Fig. 20 U.S. Healthcare Third-party Logistics Market for Transportation, 2018 - 2030 (USD Billion)
• Fig. 21 U.S. Healthcare Third-party Logistics Market for Air Freight, 2018 - 2030 (USD Billion)
• Fig. 22 U.S. Healthcare Third-party Logistics Market for Sea Freight, 2018 - 2030 (USD Billion)
• Fig. 23 U.S. Healthcare Third-party Logistics Market for Overland Transportation, 2018 - 2030 (USD Billion)
• Fig. 24 U.S. Healthcare Third-party Logistics Market for Warehousing and storage, 2018 - 2030 (USD Billion)
• Fig. 25 U.S. Healthcare Third-party Logistics Market for Others, 2018 - 2030 (USD Billion)
• Fig. 26 U.S. Healthcare Third-party Logistics Market for Northeast, 2018 - 2030 (USD Billion)
• Fig. 27 U.S. Healthcare Third-party Logistics Market for Southwest, 2018 - 2030 (USD Billion)
• Fig. 28 U.S. Healthcare Third-party Logistics Market for West, 2018 - 2030 (USD Billion)
• Fig. 29 U.S. Healthcare Third-party Logistics Market for Southeast, 2018 - 2030 (USD Billion)
• Fig. 30 U.S. Healthcare Third-party Logistics Market for Midwest, 2018 - 2030 (USD Billion)